{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:55:16Z","timestamp":1792760116912,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011937","name":"Nieders\u00e4chsische Ministerium f\u00fcr Wissenschaft und Kultur","doi-asserted-by":"publisher","award":["12.5-76251-12-11\/19"],"award-info":[{"award-number":["12.5-76251-12-11\/19"]}],"id":[{"id":"10.13039\/100011937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cervical cancer (CC) remains a leading cause of cancer-related mortality among women, particularly in underdeveloped or developing countries lacking adequate screening programs. Despite being highly preventable through HPV vaccinations and screening tests, and highly treatable when detected early, CC continues to pose a significant health burden. MSX1, a transcription factor of the homeobox family, plays an important role in the development and differentiation of tissues, including the gynecological tract. Since MSX1 has been identified as both a tumor suppressor and an oncogene in tumorigenesis, but its function in CC remains elusive to date, the present study aims to elucidate the role of MSX1 in CC and its precancerous stages. Our results demonstrate that MSX1 acts as a tumor-promoting factor in CC. While normal squamous epithelium of the cervix is negative for MSX1, we observed de novo expression of MSX1 in precancerous lesions. We found that MSX1 expression enhances the clonogenic and migratory capacities of cervical cancer cell lines. Mechanistic insights revealed an MSX1-dependent induction of the epithelial-to-mesenchymal transition (EMT), a process highly correlated with cancer development and progression. CUT&amp;RUN sequencing data identified enriched signaling of the cytoskeletal modulators RHO\/RAC\/CDC42 in MSX1-expressing cells, potentially mediated by MSX1. Additionally, FOS, a downstream effector of RHO, was found as a key factor contributing to CC aggressiveness. Interference with both RHO-signaling and FOS-mediated regulation completely reversed the aggressive phenotype of MSX1-expressing cells. In conclusion, our findings suggest that MSX1 plays a crucial role in cancer-related signaling pathways and may have implications for the development of therapeutic approaches in cervical cancer.<\/jats:p>","DOI":"10.1038\/s41420-026-03191-y","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:13:38Z","timestamp":1780672418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of tumor-promoting functions of the Homeobox family transcription factor MSX1 in cervical cancer"],"prefix":"10.1038","volume":"12","author":[{"given":"Paulina","family":"Br\u00fccker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaishavi","family":"Jansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Kombou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Eppich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Jeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Hakroush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"K\u00fcffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3335-3534","authenticated-orcid":false,"given":"Sonja","family":"Fritzsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0750-6998","authenticated-orcid":false,"given":"Florian","family":"Wegwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Gallwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"3191_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/CAAC.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/CAAC.21834.","journal-title":"CA Cancer J Clin"},{"key":"3191_CR2","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1002\/CNCR.30667","volume":"123","author":"W Small","year":"2017","unstructured":"Small W, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, et al. Cervical cancer: a global health crisis. Cancer. 2017;123:2404\u201312. https:\/\/doi.org\/10.1002\/CNCR.30667.","journal-title":"Cancer"},{"key":"3191_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/CAAC.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/CAAC.21660.","journal-title":"CA Cancer J Clin"},{"key":"3191_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMOA021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518\u201327. https:\/\/doi.org\/10.1056\/NEJMOA021641.","journal-title":"N Engl J Med"},{"key":"3191_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"EM Burd","year":"2003","unstructured":"Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16:1\u201317. https:\/\/doi.org\/10.1128\/CMR.16.1.1-17.2003.","journal-title":"Clin Microbiol Rev"},{"key":"3191_CR6","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1158\/2159-8290.CD-17-1018","volume":"8","author":"M Eckhardt","year":"2018","unstructured":"Eckhardt M, Zhang W, Gross AM, Von Dollen J, Johnson JR, Franks-Skiba KE, et al. Multiple routes to oncogenesis are promoted by the human papillomavirus\u2013host protein network. Cancer Discov. 2018;8:1474\u201389. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-1018.","journal-title":"Cancer Discov"},{"key":"3191_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","volume":"395","author":"M Brisson","year":"2020","unstructured":"Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395:575\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(20)30068-4.","journal-title":"Lancet"},{"key":"3191_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/J.SONCN.2019.02.003","volume":"35","author":"CA Johnson","year":"2019","unstructured":"Johnson CA, James D, Marzan A, Armaos M. Cervical cancer: an overview of pathophysiology and management. Semin Oncol Nurs. 2019;35:166\u201374. https:\/\/doi.org\/10.1016\/J.SONCN.2019.02.003.","journal-title":"Semin Oncol Nurs"},{"key":"3191_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/IJGO.13865","volume":"155","author":"N Bhatla","year":"2021","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet. 2021;155:28\u201344. https:\/\/doi.org\/10.1002\/IJGO.13865.","journal-title":"Int J Gynaecol Obstet"},{"key":"3191_CR10","doi-asserted-by":"publisher","unstructured":"\u0160arenac T, Mikov M. Cervical cancer, different treatments and importance of bile acids as therapeutic agents in this disease. Front Pharmacol. 2019;10. https:\/\/doi.org\/10.3389\/FPHAR.2019.00484.","DOI":"10.3389\/FPHAR.2019.00484"},{"key":"3191_CR11","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/0888-7543(91)90074-O","volume":"11","author":"JE Hewitt","year":"1991","unstructured":"Hewitt JE, Clark LN, Ivens A, Williamson R. Structure and sequence of the human homeobox gene HOX7. Genomics. 1991;11:670\u20138. https:\/\/doi.org\/10.1016\/0888-7543(91)90074-O.","journal-title":"Genomics"},{"key":"3191_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0168-9525(00)89124-6","volume":"11","author":"D Davidson","year":"1995","unstructured":"Davidson D. The function and evolution of Msx genes: pointers and paradoxes. Trends Genet. 1995;11:405\u201311. https:\/\/doi.org\/10.1016\/S0168-9525(00)89124-6.","journal-title":"Trends Genet"},{"key":"3191_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/J.CANEP.2010.06.003","volume":"34","author":"T Sliwinski","year":"2010","unstructured":"Sliwinski T, Synowiec E, Czarny P, Gomulak P, Forma E, Morawiec Z, et al. The c.469+46_56del mutation in the homeobox MSX1 gene-a novel risk factor in breast cancer? Cancer Epidemiol. 2010;34:652\u20135. https:\/\/doi.org\/10.1016\/J.CANEP.2010.06.003.","journal-title":"Cancer Epidemiol"},{"key":"3191_CR14","doi-asserted-by":"publisher","unstructured":"Li TF, Zeng HJ, Shan Z, Ye RY, Cheang TY, Zhang YJ, et al. Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer. Cancer Cell Int. 2020;20. https:\/\/doi.org\/10.1186\/S12935-020-01191-1.","DOI":"10.1186\/S12935-020-01191-1"},{"key":"3191_CR15","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.2147\/OTT.S165144","volume":"11","author":"Y Yue","year":"2018","unstructured":"Yue Y, Zhou K, Li J, Jiang S, Li C, Men H. MSX1 induces G0\/G1 arrest and apoptosis by suppressing Notch signaling and is frequently methylated in cervical cancer. Onco Targets Ther. 2018;11:4769\u201380. https:\/\/doi.org\/10.2147\/OTT.S165144.","journal-title":"Onco Targets Ther"},{"key":"3191_CR16","doi-asserted-by":"publisher","first-page":"810","DOI":"10.21037\/ATM-21-220","volume":"9","author":"C Liu","year":"2021","unstructured":"Liu C, Huang M, Han C, Li H, Wang J, Huang Y, et al. A narrative review of the roles of muscle segment homeobox transcription factor family in cancer. Ann Transl Med. 2021;9:810\u2013810. https:\/\/doi.org\/10.21037\/ATM-21-220.","journal-title":"Ann Transl Med"},{"key":"3191_CR17","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1006\/BBRC.2001.4474","volume":"281","author":"J Park","year":"2001","unstructured":"Park J, Park K, Kim S, Lee JH. Msx1 gene overexpression induces G1 phase cell arrest in human ovarian cancer cell line OVCAR3. Biochem Biophys Res Commun. 2001;281:1234\u201340. https:\/\/doi.org\/10.1006\/BBRC.2001.4474.","journal-title":"Biochem Biophys Res Commun"},{"key":"3191_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21124529","volume":"21","author":"S Eppich","year":"2020","unstructured":"Eppich S, Kuhn C, Schmoeckel E, Mayr D, Mahner S, Jeschke U, et al. Msx1\u2014A potential marker for uterus-preserving therapy of endometrial carcinomas. Int J Mol Sci. 2020;21:1\u201313. https:\/\/doi.org\/10.3390\/ijms21124529.","journal-title":"Int J Mol Sci"},{"key":"3191_CR19","doi-asserted-by":"publisher","unstructured":"Xu J, Liu H, Yang Y, Wang X, Liu P, Li Y, et al. Genome-wide profiling of cervical RNA-binding proteins identifies human papillomavirus regulation of RNASEH2A expression by viral E7 and E2F1. mBio; 2019;10. https:\/\/doi.org\/10.1128\/MBIO.02687-18.","DOI":"10.1128\/MBIO.02687-18"},{"key":"3191_CR20","doi-asserted-by":"publisher","first-page":"30975","DOI":"10.1074\/JBC.M502315200","volume":"280","author":"N Rave-Harel","year":"2005","unstructured":"Rave-Harel N, Miller NLG, Givens ML, Mellon PL. The Groucho-related gene family regulates the gonadotropin-releasing hormone gene through interaction with the homeodomain proteins MSX1 and OCT1. J Biol Chem. 2005;280:30975\u201383. https:\/\/doi.org\/10.1074\/JBC.M502315200.","journal-title":"J Biol Chem"},{"key":"3191_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/J.DEVCEL.2011.07.003","volume":"21","author":"J Wang","year":"2011","unstructured":"Wang J, Kumar RM, Biggs VJ, Lee H, Chen Y, Kagey MH, et al. The Msx1 homeoprotein recruits polycomb to the nuclear periphery during development. Dev Cell. 2011;21:575\u201388. https:\/\/doi.org\/10.1016\/J.DEVCEL.2011.07.003.","journal-title":"Dev Cell"},{"key":"3191_CR22","doi-asserted-by":"publisher","first-page":"11452","DOI":"10.1093\/NAR\/GKAA905","volume":"48","author":"Y Yang","year":"2020","unstructured":"Yang Y, Zhu X, Jia X, Hou W, Zhou G, Ma Z, et al. Phosphorylation of Msx1 promotes cell proliferation through the Fgf9\/18-MAPK signaling pathway during embryonic limb development. Nucleic Acids Res. 2020;48:11452\u201367. https:\/\/doi.org\/10.1093\/NAR\/GKAA905.","journal-title":"Nucleic Acids Res"},{"key":"3191_CR23","doi-asserted-by":"publisher","unstructured":"Zubor P, Dankova Z, Kolkova Z, Holubekova V, Brany D, Mersakova S, et al. Rho GTPases in gynecologic cancers: in-depth analysis toward the paradigm change from reactive to predictive, preventive, and personalized medical approach benefiting the patient and healthcare. Cancers. 2020;12. https:\/\/doi.org\/10.3390\/CANCERS12051292.","DOI":"10.3390\/CANCERS12051292"},{"key":"3191_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.PHARMTHERA.2017.09.002","volume":"183","author":"S Jansen","year":"2018","unstructured":"Jansen S, Gosens R, Wieland T, Schmidt M. Paving the Rho in cancer metastasis: Rho GTPases and beyond. Pharmacol Ther. 2018;183:1\u201321. https:\/\/doi.org\/10.1016\/J.PHARMTHERA.2017.09.002.","journal-title":"Pharmacol Ther"},{"key":"3191_CR25","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/J.CELLSIG.2013.04.009","volume":"25","author":"S Hanna","year":"2013","unstructured":"Hanna S, El-Sibai M. Signaling networks of Rho GTPases in cell motility. Cell Signal. 2013;25:1955\u201361. https:\/\/doi.org\/10.1016\/J.CELLSIG.2013.04.009.","journal-title":"Cell Signal"},{"key":"3191_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/NATURE09823","volume":"472","author":"H Murakoshi","year":"2011","unstructured":"Murakoshi H, Wang H, Yasuda R. Local, persistent activation of Rho GTPases during plasticity of single dendritic spines. Nature. 2011;472:100\u20136. https:\/\/doi.org\/10.1038\/NATURE09823.","journal-title":"Nature"},{"key":"3191_CR27","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1158\/0008-5472.CAN-12-0954","volume":"72","author":"RA Patel","year":"2012","unstructured":"Patel RA, Forinash KD, Pireddu R, Sun Y, Sun N, Martin MP, et al. RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer. Cancer Res. 2012;72:5025\u201334. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-0954.","journal-title":"Cancer Res"},{"key":"3191_CR28","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1038\/ONC.2016.163","volume":"35","author":"AL Hein","year":"2016","unstructured":"Hein AL, Post CM, Sheinin YM, Lakshmanan I, Natarajan A, Enke CA, et al. RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment. Oncogene. 2016;35:6319\u201329. https:\/\/doi.org\/10.1038\/ONC.2016.163.","journal-title":"Oncogene"},{"key":"3191_CR29","first-page":"3645","volume":"31","author":"CA Street","year":"2011","unstructured":"Street CA, Bryan BA. Rho kinase proteins\u2014pleiotropic modulators of cell survival and apoptosis. Anticancer Res. 2011;31:3645.","journal-title":"Anticancer Res"},{"key":"3191_CR30","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez R, Lorenzo-Mart\u00edn LF, Quesada V, Bustelo XR. Pan-cancer analyses identify oncogenic drivers, expression signatures, and therapeutic vulnerabilities in RHO GTPase pathway genes. Front Bioinform. 2025;5. https:\/\/doi.org\/10.3389\/FBINF.2025.1708800.","DOI":"10.3389\/FBINF.2025.1708800"},{"key":"3191_CR31","doi-asserted-by":"publisher","unstructured":"Yu W, Gu Y, Zhang H, Huang W, Sun L, Ma L, et al. SF3A3 drives tumorigenesis in endometrial cancer by enhancing c-FOS expression and represents a potential therapeutic target. Adv Sci. 2025;12. https:\/\/doi.org\/10.1002\/ADVS.202504184.","DOI":"10.1002\/ADVS.202504184"},{"key":"3191_CR32","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/J.CELLSIG.2013.02.019","volume":"25","author":"N Benbernou","year":"2013","unstructured":"Benbernou N, Esnault S, Galibert F. Activation of SRE and AP1 by olfactory receptors via the MAPK and Rho dependent pathways. Cell Signal. 2013;25:1486\u201397. https:\/\/doi.org\/10.1016\/J.CELLSIG.2013.02.019.","journal-title":"Cell Signal"},{"key":"3191_CR33","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/J.EJCA.2005.08.008","volume":"41","author":"K Milde-Langosch","year":"2005","unstructured":"Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer. 2005;41:2449\u201361. https:\/\/doi.org\/10.1016\/J.EJCA.2005.08.008.","journal-title":"Eur J Cancer"},{"key":"3191_CR34","doi-asserted-by":"publisher","unstructured":"Son MJ, Rho SB, Kim K, Oh M, Son C, Song SY, et al. Homeoprotein Msx1-PIASy interaction inhibits angiogenesis. Cells. 2020;9. https:\/\/doi.org\/10.3390\/CELLS9081854.","DOI":"10.3390\/CELLS9081854"},{"key":"3191_CR35","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1158\/1078-0432.CCR-15-1669","volume":"22","author":"NA Bonito","year":"2016","unstructured":"Bonito NA, Borley J, Wilhelm-Benartzi CS, Ghaem-Maghami S, Brown R. Epigenetic regulation of the homeobox gene MSX1 associates with platinum-resistant disease in high-grade serous epithelial ovarian cancer. Clin Cancer Res. 2016;22:3097\u2013104. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1669.","journal-title":"Clin Cancer Res"},{"key":"3191_CR36","doi-asserted-by":"publisher","unstructured":"Mori T, Ueno K, Tokunaga K, Kawai Y, Matsuda K, Nishida N, et al. A single-nucleotide-polymorphism in the 5\u2019-flanking region of MSX1 gene as a predictive marker candidate for platinum-based therapy of esophageal carcinoma. Ther Adv Med Oncol. 2022;14. https:\/\/doi.org\/10.1177\/17588359221080580.","DOI":"10.1177\/17588359221080580"},{"key":"3191_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/J.JID.2017.05.038","volume":"138","author":"MV Heppt","year":"2018","unstructured":"Heppt MV, Wang JX, Hristova DM, Wei Z, Li L, Evans B, et al. MSX1-induced neural crest-like reprogramming promotes melanoma progression. J Invest Dermatol. 2018;138:141\u20139. https:\/\/doi.org\/10.1016\/J.JID.2017.05.038.","journal-title":"J Invest Dermatol"},{"key":"3191_CR38","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/S41388-022-02189-X","volume":"41","author":"H Wu","year":"2022","unstructured":"Wu H, Ding X, Hu X, Zhao Q, Chen Q, Sun T, et al. LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer. Oncogene. 2022;41:1959\u201373. https:\/\/doi.org\/10.1038\/S41388-022-02189-X.","journal-title":"Oncogene"},{"key":"3191_CR39","doi-asserted-by":"publisher","unstructured":"Yang Y, Jia X, Peng Y, Lu S, Wang C, Zhang H, et al. Phosphorylation of MSX1 controls tumorigenesis and bone development through targeting FBXW7 degradation. Cancer Lett. 2025;631. https:\/\/doi.org\/10.1016\/J.CANLET.2025.217948.","DOI":"10.1016\/J.CANLET.2025.217948"},{"key":"3191_CR40","doi-asserted-by":"publisher","unstructured":"Horazna M, Janeckova L, Svec J, Babosova O, Hrckulak D, Vojtechova M, et al. Msx1 loss suppresses formation of the ectopic crypts developed in the Apc-deficient small intestinal epithelium. Sci Rep. 2019;9. https:\/\/doi.org\/10.1038\/S41598-018-38310-Y.","DOI":"10.1038\/S41598-018-38310-Y"},{"key":"3191_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/S11684-018-0656-6","volume":"12","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Weinberg RA. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. Front Med. 2018;12:361\u201373. https:\/\/doi.org\/10.1007\/S11684-018-0656-6.","journal-title":"Front Med"},{"key":"3191_CR42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cytogfr.2024.09.002","volume":"80","author":"C Liu","year":"2024","unstructured":"Liu C, Chen S, Zhang Y, Zhou X, Wang H, Wang Q, et al. Mechanisms of Rho GTPases in regulating tumor proliferation, migration and invasion. Cytokine Growth Factor Rev. 2024;80:168\u2013174. https:\/\/doi.org\/10.1016\/j.cytogfr.2024.09.002.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3191_CR43","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/ONC.2012.634","volume":"33","author":"RA Patel","year":"2014","unstructured":"Patel RA, Liu Y, Wang B, Li R, Sebti SM. Identification of novel ROCK inhibitors with anti-migratory and anti-invasive activities. Oncogene. 2014;33:550\u20135. https:\/\/doi.org\/10.1038\/ONC.2012.634.","journal-title":"Oncogene"},{"key":"3191_CR44","doi-asserted-by":"publisher","first-page":"8742","DOI":"10.1158\/0008-5472.CAN-09-1541","volume":"69","author":"S Liu","year":"2009","unstructured":"Liu S, Goldstein RH, Scepansky EM, Rosenblatt M. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone. Cancer Res. 2009;69:8742\u201351. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1541.","journal-title":"Cancer Res"},{"key":"3191_CR45","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1038\/s41388-021-01814-5","volume":"40","author":"E Prokakis","year":"2021","unstructured":"Prokakis E, Dyas A, Gr\u00fcn R, Fritzsche S, Bedi U, Kazerouni ZB, et al. USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response. Oncogene. 2021;40:4004\u201318. https:\/\/doi.org\/10.1038\/s41388-021-01814-5.","journal-title":"Oncogene"},{"key":"3191_CR46","doi-asserted-by":"publisher","unstructured":"Wegwitz F, Prokakis E, Pejkovska A, Kosinsky RL, Glatzel M, Pantel K, et al. The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis. Cell Death Dis. 2020;11. https:\/\/doi.org\/10.1038\/s41419-020-03081-w.","DOI":"10.1038\/s41419-020-03081-w"},{"key":"3191_CR47","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/NMETH.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357\u201360. https:\/\/doi.org\/10.1038\/NMETH.3317.","journal-title":"Nat Methods"},{"key":"3191_CR48","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330. https:\/\/doi.org\/10.1093\/bioinformatics\/btt656.","journal-title":"Bioinformatics"},{"key":"3191_CR49","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550 https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"3191_CR50","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/BIOINFORMATICS\/BTV145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu G, Wang LG, He QY. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics. 2015;31:2382\u20133. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTV145.","journal-title":"Bioinformatics"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03191-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03191-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03191-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:28:39Z","timestamp":1780673319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03191-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3191"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03191-y","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"TCGA patient data and IHC patient CC biopsy material were collected with their consent and approved by the local ethical authorities (application #38\/4\/24).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"270"}}